Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.

Berge G, Sando SB, Albrektsen G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, White LR.

BMC Neurol. 2016 Sep 21;16(1):180.

2.

The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release.

Neasta J, Valmalle C, Coyne AC, Carnazzi E, Subra G, Galleyrand JC, Gagne D, M'Kadmi C, Bernad N, Bergé G, Cantel S, Marin P, Marie J, Banères JL, Kemel ML, Daugé V, Puget K, Martinez J.

Br J Pharmacol. 2016 Apr;173(8):1314-28. doi: 10.1111/bph.13424. Epub 2016 Mar 8.

PMID:
27027724
3.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.

Lauridsen C, Sando SB, Shabnam A, Møller I, Berge G, Grøntvedt GR, Bakken IJ, Salvesen Ø, Bråthen G, White LR.

Front Aging Neurosci. 2016 Mar 1;8:30. doi: 10.3389/fnagi.2016.00030. eCollection 2016.

4.

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.

Vijayaraghavan S, Darreh-Shori T, Rongve A, Berge G, Sando SB, White LR, Auestad BH, Witoelar A, Andreassen OA, Ulstein ID, Aarsland D.

J Alzheimers Dis. 2015;50(2):567-76. doi: 10.3233/JAD-150750.

PMID:
26757188
5.

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.

Berge G, Lauridsen C, Sando SB, Holder DJ, Møller I, Aasly JO, Bråthen G, Savage MJ, White LR.

J Alzheimers Dis. 2015;49(2):493-502. doi: 10.3233/JAD-150234.

PMID:
26484901
6.

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.

Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM.

Cancer Immunol Immunother. 2015 Jun;64(6):769-76. doi: 10.1007/s00262-015-1686-4. Epub 2015 Apr 2.

PMID:
25832001
7.

Soya Saponins Induce Enteritis in Atlantic Salmon (Salmo salar L.).

Krogdahl Å, Gajardo K, Kortner TM, Penn M, Gu M, Berge GM, Bakke AM.

J Agric Food Chem. 2015 Apr 22;63(15):3887-902. doi: 10.1021/jf506242t. Epub 2015 Apr 10.

PMID:
25798699
8.

Human health risk associated with brominated flame-retardants (BFRs).

Lyche JL, Rosseland C, Berge G, Polder A.

Environ Int. 2015 Jan;74:170-80. doi: 10.1016/j.envint.2014.09.006. Epub 2014 Oct 29. Review.

PMID:
25454234
9.

[G.E. Berge replies].

Berge GE.

Tidsskr Nor Laegeforen. 2014 Aug 19;134(15):1448. doi: 10.4045/tidsskr.14.0913. eCollection 2014 Aug 19. Norwegian. No abstract available.

10.

[The animal welfare act should be expanded to include children].

Berge GE.

Tidsskr Nor Laegeforen. 2014 May 27;134(10):1029. doi: 10.4045/tidsskr.14.0473. eCollection 2014 May 27. Norwegian. No abstract available.

11.

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B.

Cancer Immunol Immunother. 2014 Jun;63(6):601-13. doi: 10.1007/s00262-014-1540-0. Epub 2014 Mar 28.

12.

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.

Berge G, Sando SB, Rongve A, Aarsland D, White LR.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1227-31. doi: 10.1136/jnnp-2013-307228. Epub 2014 Mar 17.

13.

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM.

BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540.

14.

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.

Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K.

BMC Cancer. 2012 Aug 1;12:333.

15.

Medium-chain and long-chain fatty acids have different postabsorptive fates in Atlantic salmon.

Denstadli V, Bakke AM, Berge GM, Krogdahl A, Hillestad M, Holm H, Ruyter B.

J Nutr. 2011 Sep;141(9):1618-28. doi: 10.3945/jn.111.141820. Epub 2011 Jul 13.

16.

Comment on the Importance of S100A4 in regulation of MMP-13.

Berge G, Andersen K, Haugen MH, Maelandsmo GM.

J Biol Chem. 2010 Dec 31;285(53):le23; author reply le24. doi: 10.1074/jbc.L110.125898. No abstract available.

17.

Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.

Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM.

Int J Cancer. 2011 Aug 15;129(4):780-90. doi: 10.1002/ijc.25735. Epub 2011 Mar 11.

18.

Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.

Gozé C, Bergé G, M'Kadmi C, Floquet N, Gagne D, Galleyrand JC, Fehrentz JA, Martinez J.

Eur J Pharmacol. 2010 Sep 25;643(2-3):153-61. doi: 10.1016/j.ejphar.2010.06.018. Epub 2010 Jun 30.

PMID:
20599926
19.

Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide.

Berge G, Eliassen LT, Camilio KA, Bartnes K, Sveinbjørnsson B, Rekdal O.

Cancer Immunol Immunother. 2010 Aug;59(8):1285-94. doi: 10.1007/s00262-010-0857-6. Epub 2010 Apr 27.

PMID:
20422410
20.

Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.

Berge G, Costea DE, Berg M, Rasmussen H, Grotterød I, Lothe RA, Mælandsmo GM, Flatmark K.

Amino Acids. 2011 Oct;41(4):875-84. doi: 10.1007/s00726-010-0514-6. Epub 2010 Feb 27.

PMID:
20191297
Items per page

Supplemental Content

Write to the Help Desk